We identified ADAMTS16 as novel gene with cancer-specific promoter hypermethylation in CRC, LC and SCC patients implicating ADAMTS16 as potential biomarker for these tumors. This evidence concerns the gene ADAMTS16 and laryngotracheoesophageal cleft.